Beam Therapeutics Inc
NASDAQ:BEAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
Gurit Holding AG
F:GVM
|
CH |
|
F
|
First Majestic Silver Corp
F:FMV
|
CA |
|
Biotalys NV
F:86C
|
BE |
|
S
|
SLM Corp
XMUN:SM1
|
US |
|
F
|
Fluent Inc
F:7TM
|
US |
|
Robit Oyj
F:RO3
|
FI |
|
M
|
Mon Courtier Energie SAS
PAR:ALMCE
|
FR |
|
A
|
AXA SA
PAR:CSNV
|
FR |
|
Bilfinger SE
F:GBF
|
DE |
|
O
|
Olin Corp
F:OLN
|
US |
Shareholder Yield
Current shareholder yield for BEAM is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
BEAM Price
Beam Therapeutics Inc
| Average Annual Return | -26.73% |
| Standard Deviation of Annual Returns | 19.84% |
| Max Drawdown | -87% |
| Market Capitalization | 3.6B USD |
| Shares Outstanding | 102 880 000 |
| Percentage of Shares Shorted | 42.63% |
